SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-13-069879
Filing Date
2013-09-13
Accepted
2013-09-13 16:02:32
Documents
3
Group Members
BRGO CORP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a13-18444_18sc13da.htm SC 13D/A 70165
2 EX-99.(A)(5)(H) a13-18444_18ex99da5h.htm EX-99.(A)(5)(H) 11402
3 GRAPHIC g1844416mmi001.jpg GRAPHIC 3627
  Complete submission text file 0001104659-13-069879.txt   88260
Mailing Address 65 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 65 HAYDEN AVENUE LEXINGTON MA 02421 781-860-8660
CUBIST PHARMACEUTICALS INC (Filed by) CIK: 0000912183 (see all company filings)

IRS No.: 223192085 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DR SUITE 105 SAN DIEGO CA 92121 858-452-0370
Trius Therapeutics Inc (Subject) CIK: 0001356857 (see all company filings)

IRS No.: 201320630 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-85614 | Film No.: 131096423
SIC: 2834 Pharmaceutical Preparations